CCDC85C expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.30180000001978E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.237700E-02 |
Normal-vs-Stage2 |
2.076500E-03 |
Normal-vs-Stage3 |
2.58929999663593E-09 |
Normal-vs-Stage4 |
6.15389994518267E-09 |
Stage1-vs-Stage2 |
3.347600E-02 |
Stage1-vs-Stage3 |
1.06020000001372E-06 |
Stage1-vs-Stage4 |
1.61617999999697E-05 |
Stage2-vs-Stage3 |
4.619400E-01 |
Stage2-vs-Stage4 |
1.797440E-01 |
Stage3-vs-Stage4 |
3.553600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.7224999999429E-07 |
Normal-vs-AfricanAmerican |
3.348800E-01 |
Normal-vs-Asian |
4.940300E-03 |
Caucasian-vs-AfricanAmerican |
8.324400E-02 |
Caucasian-vs-Asian |
4.428400E-01 |
AfricanAmerican-vs-Asian |
2.071800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.42189995520215E-09 |
Normal-vs-Female |
4.235800E-02 |
Male-vs-Female |
6.603200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.997800E-02 |
Normal-vs-Age(41-60Yrs) |
2.369000E-04 |
Normal-vs-Age(61-80Yrs) |
9.71890000034392E-07 |
Normal-vs-Age(81-100Yrs) |
1.498470E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.159000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.111000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.523800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.467400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.331600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.358400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.697990E-01 |
Normal-vs-Grade 2 |
2.093600E-02 |
Normal-vs-Grade 3 |
2.72860000150033E-08 |
Normal-vs-Grade 4 |
1.85551574105602E-12 |
Grade 1-vs-Grade 2 |
7.298300E-02 |
Grade 1-vs-Grade 3 |
6.807500E-04 |
Grade 1-vs-Grade 4 |
3.24599999990127E-07 |
Grade 2-vs-Grade 3 |
7.391600E-04 |
Grade 2-vs-Grade 4 |
3.28299998297865E-09 |
Grade 3-vs-Grade 4 |
2.280200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.202990E-01 |
Normal-vs-ccB subtype |
8.81920003692471E-09 |
ccA subtype-vs-ccB subtype |
1.9298000000223E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.81709999996982E-06 |
Normal-vs-N1 |
1.12429999754582E-08 |
N0-vs-N1 |
6.838600E-04 |
|
|